Summary: Researchers have conducted a study to explore whether the sleep-promoting drug suvorexant can reduce delirium in older adults since insomnia is a risk factor for delirium. Delirium, a condition common in older hospitalized patients, leads to increased risks of falls, … [Read more...]
Insomnia Drug Suvorexant Increases Fat Burning During Sleep
Summary: A new randomized, double-blind, placebo-controlled crossover study has found that suvorexant, an orexin receptor antagonist approved for treating insomnia, promotes fat oxidation and reduces protein catabolism during sleep without significantly changing total sleep time. … [Read more...]
Suvorexant: A Potential Solution for Opioid Addiction
Summary: Suvorexant, an insomnia drug, prevents opioid addiction in mice when given with morphine, without inducing sleep and while maintaining effective pain relief. The drug blocks hypocretin receptors, which are linked to mood and addiction. The study shows that suvorexant … [Read more...]